Treatment with peginterferon alfa-2a (40KD) (PEGASYS®) results in improved rates of response compared to conventional interferon in patients with HBEAG positive chronic hepatitis B harboring HBV genotypes B or ‘difficult-to-treat’ genotype C

✍ Scribed by W.G.E. Cooksley; M.-Y. Lai; T. Piratvisuth; Y.-J. Wang; V. Mahachai; Y.-C. Chao; T. Tanwandee; A. Chutaputti; W.-Y. Chang; F.E. Zahm; N. Pluck

• Book ID: 118566041
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 135 KB
• Volume: 38
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(03)80483-x